What is Gemcitabine?

Category: Prescription Drugs

Most popular types: Gemzar

false

See also: GEMOX protocol IGEV regimen

Gemcitabine is an anticancer drug used for breast cancer; nonsmall cell lung cancer or pancreatic cancer; advanced, relapsed ovarian cancer. It is used for Hodgkin’s and non-Hodgkin’s lymphomas, bladder, cervical, hepatobiliary cancers and pleural mesothelioma.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Non-small cell lung cancer 2 0
Ovarian cancer 2 1
Pancreatic cancer 2 2
Breast cancer 1 1
Lung cancer 1 0
Renal cell cancer 1 0

  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 1
Moderate 2
Mild 1
None 0

Commonly reported side effects and conditions associated with Gemcitabine

Side effect Patients
Fatigue 3
Mouth sores (ulcers) 2
Brain fog 1
Fever 1
Hair loss 1
Hypersensitivity pneumonitis 1

Show all 8 reported side effects

Why patients stopped taking Gemcitabine

Multiple reasons could be selected

Reason Patients
Did not seem to work 2
Course of treatment ended 1
Other 1
See all 4 patients who've stopped taking Gemcitabine

Duration

Stopped taking Gemcitabine

Duration Patients
Less than 1 month 1
1 - 6 months 2
2 - 5 years 1
Adherence
Adherence Evaluations
Always 3
Usually 0
Sometimes 0
Never taken as prescribed 1
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 3
A little hard to take 0
Not at all hard to take 1
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 0
$25-49 0
< $25 2
Not specified 2

What people switch to and from

Patients started taking Gemcitabine after stopping:

Treatment Patients
Tamoxifen (Nolvadex) 1

Patients stopped taking Gemcitabine and switched to:

Treatment Patients
Eribulin (Halaven) 1
Fluorouracil 1
Last updated:
There are no evaluations for Gemcitabine.